West Pharmaceutical Services (WST)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 994 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1790.80% | 1,558 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 87 | 0.00 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 137.07% | 57,790 | 0.08 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 42,160 | 0.06 | |
| Q2 2012 | |||||
| ≡ | Ruane Cunniff - Sequoia Fund | Buy | 441,314 | 0.26 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.